Studies on the regulation of cholesteryl ester synthesis and mechanism of lipid accumulation in macrophage cells

巨噬细胞胆固醇酯合成调控及脂质积累机制研究

基本信息

项目摘要

Macrophage cells derived from the human monocytic leukemia cell line, THP-1, accumulate esterified cholesterol when cultivated in the presence of acetylated low-density lipoprotein(Ac-LDL) through scavenger receptors (ScR). In the present study, we isolated a subtype of THP-1 cells that failed to accumulate esterified cholesterol when cultivated in the presence of Ac-LDL.The cells had negligible amounts of cell-association and degradation of Ac-LCL compared to the parent THP-1 cell. The subtype THP-1 cells did not express ScR mRNA as well as that of lipoprotein lipase. In contrast, the expression of apolipoprotein E mRNA was greater than that found in parent THP-1 cells. The culture medium of subtype THP-1 cells treated with 12-O-tetradecanoyl-phorbol-13-acetate (TPA) inhibited the uptake of Ac-LDL and the expression of ScR in parent THP-1 cells. After 48 h incubation in the culture medium containing TPA,the culture medium of differentiated subtype THP-1 cells contained 6.9 ng/ml of tr … More ansforming growth factor (TGF)-beta1, while that of parent THP-1 cells secreted below detection level, which was less than 3 ng/ml. This inhibitory effect of the conditioned medium on the expression of ScR in parent THP-1 cells was abolished by pre-treatment of the culture medium with anti-TGF-beta1 antibodies. Parent THP-1 cells expressed as much amount of TGF-beta1 mRNA as sTHP-1 cells after stimulation of differentiation. Although the precursor forms of TGF-beta1 which were synthesized in both parent and subtype THP-1 cells were of similar size and were expressed at similar levels, latent TGF-beta1-binding protein (LTBP), which is necessary for the secretion of TGF-beta1, could only be co-immunoprecititated with anti- TGF-beta1 antibody from subtype THP-1 cells. This suggests that subtype THP-1 cells secrete TGF-beta1 into the medium by forming a functional complex with LTBp. We conclude that subtype THP-1 cells could not take up Ac-LDL because ScR was inhibited (leading a loss of function) caused by the secreted TGF-beta1. Less
来源于人类单核细胞白血病细胞系THP-1的巨噬细胞在乙酰化低密度脂蛋白(Ac-LDL)存在下通过清除率受体(ScR)培养时积累了酯化胆固醇。在本研究中,我们分离了一种THP-1细胞亚型,当在Ac-LDL存在下培养时,它不能积累酯化胆固醇。与亲本THP-1细胞相比,细胞的Ac-LCL关联和降解量可忽略不计。THP-1亚型细胞不表达ScR mRNA,也不表达脂蛋白脂肪酶。载脂蛋白E mRNA的表达明显高于亲本THP-1细胞。经TPA处理的THP-1亚型细胞培养基可抑制亲本THP-1细胞对Ac-LDL的摄取和ScR的表达。在含TPA的培养基中培养48 h后,分化亚型THP-1细胞的培养基中含有6.9 ng/ml的转化生长因子(TGF)- β 1,而亲本THP-1细胞分泌低于检测水平,小于3 ng/ml。条件培养基对亲本THP-1细胞中ScR表达的抑制作用通过抗tgf - β 1抗体预处理培养基而消除。亲本THP-1细胞在刺激分化后表达的tgf - β 1 mRNA量与sTHP-1细胞一样多。虽然在亲本细胞和亚型THP-1细胞中合成的TGF-beta1的前体形式大小相似,表达水平也相似,但分泌TGF-beta1所必需的潜伏TGF-beta1结合蛋白(LTBP)只能与来自亚型THP-1细胞的抗TGF-beta1抗体共同免疫沉淀。这表明THP-1亚型细胞通过与LTBp形成功能复合物将tgf - β 1分泌到培养基中。我们得出结论,THP-1亚型细胞不能吸收Ac-LDL,因为分泌的tgf - β 1导致ScR被抑制(导致功能丧失)。少

项目成果

期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nishimra.N: "Acquistion of secretion transforming growth factor-1 leands to autonomous suppression of scavenger receptor activity in a monocyte-macrophage cell line TIIP-1" J.Biol.Chem. 273. 1562-1567 (1998)
Nishimra.N:“分泌转化生长因子-1 的获得倾向于自主抑制单核巨噬细胞系 TIIP-1 中的清道夫受体活性”J.Biol.Chem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Varret, M., Robes, J.-P., Thiart, R., Kotze, M.J., Baron, H., Cenarro, A., Descamps, O., Ebhardt, M., Hondeliji, J.-C., Kostner, G.M., Miyake, Y., Pocovi, M., Schmidt, H., Schmidt, H., Schuster, H., Stuhrmann, M., Yamamura, T., Junien, C., Beroud, C.and B
Varret, M.、Robes, J.-P.、Thiart, R.、Kotze, M.J.、Baron, H.、Cenarro, A.、Descamps, O.、Ebhardt, M.、Hondeliji, J.-C.、
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nishimura,N: "Acquisition of secretion of transforming growth factor-β1 leads to autonomous suppression of scavenger receptor activity in a monocyte-macrophage cell line THP-1" J.Biol.Chem. 16 3. 1562-1567 (1998)
Nishimura, N:“获得转化生长因子-β1 的分泌导致单核巨噬细胞系 THP-1 中清道夫受体活性的自主抑制”J.Biol.Chem. 16 3. 1562-1567 (1998)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Harada- Shiba, M: "Kinetic analysis of cholesterol and Lp (a) using the rebound curve after LDL-apheresis" Jpn. J. Apheresis. 15. 96-97 (1995)
Harada- Shiba, M:“使用 LDL 分离后的回弹曲线对胆固醇和 Lp (a) 进行动力学分析”Jpn。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nishimura, N., Harada-Shiba, M., Tajima, S., Sugano, R., Yamamura, T., Qiang, Q.Z.and Yamamoto, A.: "Acquisition of secretion of transforming growth factor-beta1 leads to autonomous suppression of scavenger receptor activity in a monocyte-macrophage cell
Nishimura, N.、Harada-Shiba, M.、Tajima, S.、Sugano, R.、Yamamura, T.、Qiang, Q.Z. 和 Yamamoto, A.:“转化生长因子-β1 分泌的获得导致自主抑制
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMAMURA Taku其他文献

YAMAMURA Taku的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMAMURA Taku', 18)}}的其他基金

Medical examinations for obesity and hyperlipidemia with a focus on pediatric metabolic syndrome, and abnormalities of plasma lipoprotein
肥胖和高脂血症的体检,重点关注小儿代谢综合征和血浆脂蛋白异常
  • 批准号:
    22590525
  • 财政年份:
    2010
  • 资助金额:
    $ 4.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Remnant Lipoprotein Metabolism in Metabolic Syndrome, and the State of Obesity and Hyperlipidemia in Schoolchildren
代谢综合征中的残余脂蛋白代谢及学龄儿童的肥胖和高脂血症状况
  • 批准号:
    19590558
  • 财政年份:
    2007
  • 资助金额:
    $ 4.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pathophysiology of high remnant lipoproteinemia underlying atherosclerotic disease in Japan and development of a new assay for remnant lipoproteins
日本动脉粥样硬化性疾病高残留脂蛋白血症的病理生理学以及残留脂蛋白新检测方法的开发
  • 批准号:
    16590455
  • 财政年份:
    2004
  • 资助金额:
    $ 4.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on Hyperlipoproteinemic Trait, Especially Plasma Apolipoprotein Mutants, as a Risk Factor for Atherosclerosis
高脂蛋白血症特征,特别是血浆载脂蛋白突变体作为动脉粥样硬化危险因素的研究
  • 批准号:
    05454325
  • 财政年份:
    1993
  • 资助金额:
    $ 4.67万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Plasma Apolipoprotein Mutants and their Implication on Lipoprotein Metabolism
血浆载脂蛋白突变体及其对脂蛋白代谢的影响
  • 批准号:
    02671116
  • 财政年份:
    1990
  • 资助金额:
    $ 4.67万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Boosting cholesterol trafficking and reducing cellular oxidation to reverse atherosclerosis and prevent vascular cognitive impairment (PREVENT-VCI)
促进胆固醇运输并减少细胞氧化,以逆转动脉粥样硬化并预防血管性认知障碍 (PREVENT-VCI)
  • 批准号:
    424826
  • 财政年份:
    2020
  • 资助金额:
    $ 4.67万
  • 项目类别:
    Operating Grants
Understanding atherosclerosis by studying the effects of cholesterol on endothelial cells
通过研究胆固醇对内皮细胞的影响来了解动脉粥样硬化
  • 批准号:
    386602
  • 财政年份:
    2017
  • 资助金额:
    $ 4.67万
  • 项目类别:
    Studentship Programs
Effects of miR-30c deficiency on plasma cholesterol and atherosclerosis
miR-30c 缺陷对血浆胆固醇和动脉粥样硬化的影响
  • 批准号:
    10424970
  • 财政年份:
    2017
  • 资助金额:
    $ 4.67万
  • 项目类别:
Cholesterol Regulation of Inflammatory Macrophages in Atherosclerosis
动脉粥样硬化中炎症巨噬细胞的胆固醇调节
  • 批准号:
    10188606
  • 财政年份:
    2017
  • 资助金额:
    $ 4.67万
  • 项目类别:
Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis
非编码RNA对胆固醇稳态和动脉粥样硬化的调节
  • 批准号:
    10570209
  • 财政年份:
    2017
  • 资助金额:
    $ 4.67万
  • 项目类别:
Effects of miR-30c deficiency on plasma cholesterol and atherosclerosis
miR-30c 缺陷对血浆胆固醇和动脉粥样硬化的影响
  • 批准号:
    9401363
  • 财政年份:
    2017
  • 资助金额:
    $ 4.67万
  • 项目类别:
Project 2: Cholesterol Regulation of Inflammatory Macrophages in Atherosclerosis
项目2:动脉粥样硬化中炎症巨噬细胞的胆固醇调节
  • 批准号:
    10334095
  • 财政年份:
    2017
  • 资助金额:
    $ 4.67万
  • 项目类别:
Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis
非编码RNA对胆固醇稳态和动脉粥样硬化的调节
  • 批准号:
    10350668
  • 财政年份:
    2017
  • 资助金额:
    $ 4.67万
  • 项目类别:
Effects of miR-30c deficiency on plasma cholesterol and atherosclerosis
miR-30c 缺陷对血浆胆固醇和动脉粥样硬化的影响
  • 批准号:
    9900861
  • 财政年份:
    2017
  • 资助金额:
    $ 4.67万
  • 项目类别:
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis
抗氧化剂 apoA1 在逆转胆固醇转运、炎症和动脉粥样硬化中的作用
  • 批准号:
    9451333
  • 财政年份:
    2016
  • 资助金额:
    $ 4.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了